1. Home
  2. PHAR vs VINP Comparison

PHAR vs VINP Comparison

Compare PHAR & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • VINP
  • Stock Information
  • Founded
  • PHAR 1988
  • VINP 2009
  • Country
  • PHAR Netherlands
  • VINP Brazil
  • Employees
  • PHAR N/A
  • VINP N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • VINP Investment Managers
  • Sector
  • PHAR Health Care
  • VINP Finance
  • Exchange
  • PHAR Nasdaq
  • VINP Nasdaq
  • Market Cap
  • PHAR 618.3M
  • VINP 641.7M
  • IPO Year
  • PHAR N/A
  • VINP 2021
  • Fundamental
  • Price
  • PHAR $8.20
  • VINP $10.27
  • Analyst Decision
  • PHAR Strong Buy
  • VINP Strong Buy
  • Analyst Count
  • PHAR 3
  • VINP 2
  • Target Price
  • PHAR $27.00
  • VINP $13.50
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • VINP 62.7K
  • Earning Date
  • PHAR 03-13-2025
  • VINP 02-26-2025
  • Dividend Yield
  • PHAR N/A
  • VINP 6.75%
  • EPS Growth
  • PHAR N/A
  • VINP N/A
  • EPS
  • PHAR N/A
  • VINP 0.60
  • Revenue
  • PHAR $285,745,000.00
  • VINP $88,217,697.00
  • Revenue This Year
  • PHAR $20.08
  • VINP $17.23
  • Revenue Next Year
  • PHAR $9.22
  • VINP $51.06
  • P/E Ratio
  • PHAR N/A
  • VINP $17.33
  • Revenue Growth
  • PHAR 30.64
  • VINP 9.03
  • 52 Week Low
  • PHAR $6.65
  • VINP $9.01
  • 52 Week High
  • PHAR $13.20
  • VINP $11.85
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 36.29
  • VINP 56.01
  • Support Level
  • PHAR $8.49
  • VINP $10.00
  • Resistance Level
  • PHAR $9.35
  • VINP $10.49
  • Average True Range (ATR)
  • PHAR 0.55
  • VINP 0.22
  • MACD
  • PHAR -0.17
  • VINP 0.07
  • Stochastic Oscillator
  • PHAR 12.14
  • VINP 72.73

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About VINP Vinci Partners Investments Ltd.

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Share on Social Networks: